Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Hamid Mojibian

Vascular & Interventional Radiology New Haven, CT Medical Doctor

NPI 1821109539 CMS profile 354762

800 Howard Ave, Yale Physicians Bldg, New Haven, CT 06519

Open in the dashboard

General payments

$22,628

106 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$251,915 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Hamid Mojibian of New Haven, CT is reported in the CMS Open Payments database as having received $22,628 across 106 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $251,915 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 86th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,778 25
2024 General $6,587 23
2023 General $2,376 9
2022 General $2,671 17
2021 General $408 5
2020 General $388 7
2019 General $1,420 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hamid Mojibian
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Hamid Mojibian were reported at $8,778. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Hamid Mojibian Vascular & Interventional Radiology median Middle half National median
2019 $1,420 $422 $125–$1,555 $163
2020 $388 $200 $68–$652 $114
2021 $408 $280 $99–$866 $132
2022 $2,671 $433 $137–$1,497 $149
2023 $2,376 $506 $152–$2,019 $160
2024 $6,587 $556 $175–$1,930 $164
2025 $8,778 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AngioDynamics, Inc. $6,247 32 payments
  2. Inari Medical, Inc. $5,348 44 payments
  3. Stryker Corporation $4,836 8 payments
  4. Penumbra, Inc. $3,547 3 payments
  5. HeartFlow, Inc. $1,279 4 payments
  6. Boston Scientific Corporation $350 2 payments
  7. Bard Peripheral Vascular, Inc. $293 4 payments
  8. Shockwave Medical, Inc $230 1 payment
  9. Philips Electronics North America Corporation $161 2 payments
  10. Aidoc Medical Ltd $155 2 payments
  11. Other $180 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $11,149 33 payments
  2. Food and Beverage $6,766 70 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,400 1 payment
  4. Consulting Fee $1,313 2 payments
Products named General payments · program years 2019–2025
  1. FLOWTRIEVER CATHETER, S $9,235 38 payments
  2. CT THROMBECTOMY SYSTEM KIT $8,419 28 payments
  3. ANGIOVAC $3,691 15 payments
  4. RUBY Coil $3,400 1 payment
  5. ALPHAVAC $2,557 17 payments
  6. FFRct $1,279 4 payments
  7. ClotTriever $1,207 18 payments
  8. FlowTriever $1,207 18 payments
  9. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $230 1 payment
  10. EMBOLD Fibered $178 1 payment
  11. Other $1,123 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 83 billing codes

Paid by Medicare

$41,728

Medicare's payments for the services billed

Medicare patients

309

Average age 74

Services billed

578

125 women, 184 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 57%
Arthritis 50%
Heart failure 43%
Diabetes 38%
Atrial fibrillation 37%
Chronic kidney disease 33%
Cancer 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

106 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record